Episode 38 - Iain Kilty, CEO of Sitryx

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.

I’m joined by Iain Kilty, CEO of Sitryx, a biotech pushing boundaries in immunology and inflammation.

Iain’s journey is fascinating—after 22 years at Pfizer, leading global drug discovery efforts, he transitioned into biotech, taking on the CSO role at Sitryx before stepping up as CEO. Now, he’s leading the charge as Sitryx enters the clinic, a huge milestone for any company.

In this episode, we dive into:

• The science behind Sitryx’s breakthrough work
• The UK biotech scene vs. the US—fundraising, growth, and challenges
• What’s next for Sitryx as they push toward transforming patient care

Enjoy and stay Tuned.